X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse J.B.Chemicals with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ADCOCK INGRAM (S. Africa) - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 J.B.CHEMICALS   ADCOCK INGRAM
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ADCOCK INGRAM
Jun-14
J.B.CHEMICALS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs318399-   
Low Rs200288-   
Sales per share (Unadj.) Rs148.0118.8-  
Earnings per share (Unadj.) Rs19.1-29.9-  
Cash flow per share (Unadj.) Rs23.9-24.8-  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.993.3-  
Shares outstanding (eoy) m84.82168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.9 60.4%   
Avg P/E ratio x13.6-11.5 -118.1%  
P/CF ratio (eoy) x10.8-13.9 -78.0%  
Price / Book Value ratio x2.03.7 54.4%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,95158,031 37.8%   
No. of employees `0002.74.3 63.7%   
Total wages/salary Rs m1,8413,642 50.6%   
Avg. sales/employee Rs Th4,590.94,671.9 98.3%   
Avg. wages/employee Rs Th673.4848.4 79.4%   
Avg. net profit/employee Rs Th592.1-1,177.2 -50.3%   
INCOME DATA
Net Sales Rs m12,55120,056 62.6%  
Other income Rs m542140 385.6%   
Total revenues Rs m13,09320,197 64.8%   
Gross profit Rs m2,055-3,476 -59.1%  
Depreciation Rs m412866 47.6%   
Interest Rs m96543 17.6%   
Profit before tax Rs m2,088-4,744 -44.0%   
Minority Interest Rs m0-13 3.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469296 158.2%   
Profit after tax Rs m1,619-5,054 -32.0%  
Gross profit margin %16.4-17.3 -94.5%  
Effective tax rate %22.5-6.2 -359.5%   
Net profit margin %12.9-25.2 -51.2%  
BALANCE SHEET DATA
Current assets Rs m7,77814,690 52.9%   
Current liabilities Rs m4,3588,265 52.7%   
Net working cap to sales %27.232.0 85.1%  
Current ratio x1.81.8 100.4%  
Inventory Days Days55111 49.3%  
Debtors Days Days80124 64.6%  
Net fixed assets Rs m5,7138,563 66.7%   
Share capital Rs m17093 182.1%   
"Free" reserves Rs m10,5470-   
Net worth Rs m10,93715,742 69.5%   
Long term debt Rs m05,532 0.0%   
Total assets Rs m15,57429,738 52.4%  
Interest coverage x22.8-7.7 -295.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 119.5%   
Return on assets %11.0-15.2 -72.6%  
Return on equity %14.8-32.1 -46.1%  
Return on capital %20.0-19.8 -100.8%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Net fx Rs m4,8840-   
CASH FLOW
From Operations Rs m1,3971,712 81.6%  
From Investments Rs m-320-526 60.9%  
From Financial Activity Rs m-1,1965,021 -23.8%  
Net Cashflow Rs m-1026,207 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.51 Rs / ZAR

Compare J.B.CHEMICALS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare J.B.CHEMICALS With: DISHMAN PHARMA  ALKEM LABORATORIES  TTK HEALTHCARE  BIOCON LTD  GLENMARK PHARMA  



Today's Market

Sensex Opens Flat; PSU & Healthcare Stocks Top Losers(09:30 am)

Asian equities are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.20% while the Hang Seng is up 0.61%. The Shanghai Composite is trading up by 0.45%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 20, 2018 10:03 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS